| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 01/05/2012 | US20120001155 Fusing porphyrins with polycyclic aromatic hydrocarbons and heterocycles for optoelectronic applications |
| 01/05/2012 | US20120001154 Aromatic amine derivative and organic electroluminescence device using the same |
| 01/05/2012 | US20120000790 Electrorecovery of metals |
| 01/05/2012 | CA2804347A1 Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof |
| 01/05/2012 | CA2804225A1 Heterocyclic compound and p27kip1 degradation inhibitor |
| 01/05/2012 | CA2803996A1 Piperidine derivatives and their use for the treatment of metabolic disorders |
| 01/05/2012 | CA2803660A1 Compound for inhibiting type 5 phosphodiesterase and preparation method thereof |
| 01/05/2012 | CA2803624A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 01/05/2012 | CA2802492A1 2-quinolinyl-acetic acid derivatives as hiv antiviral compounds |
| 01/04/2012 | EP2403028A1 Organic electroluminescent element |
| 01/04/2012 | EP2402727A1 Method for proving authenticity using naphthalocyanine compound, signal transduction method, polymer welding method, method for producing lithographic printing plate, printing ink, toner, heat-shielding material, and method for producing naphthalocyanine compound |
| 01/04/2012 | EP2402345A1 Pyrazole fused bicyclic compounds |
| 01/04/2012 | EP2402344A1 Pyrazole fused bicyclic compounds |
| 01/04/2012 | EP2402343A1 Pyrazole-fused bicyclic compounds |
| 01/04/2012 | EP2402342A1 Pharmaceutical composition for treatment of 2 type dabetes |
| 01/04/2012 | EP2402339A1 Pyrazolopyridine compounds |
| 01/04/2012 | EP2402338A1 Pyrazolopyridine compounds |
| 01/04/2012 | EP2402337A1 Pyrazolopyridine compounds |
| 01/04/2012 | EP2402334A1 Inhibitors of E1 Activating Enzymes |
| 01/04/2012 | EP2401915A1 Pyrazolopyridine compounds |
| 01/04/2012 | EP2401281A1 Pyrimidopyrimidoindazole derivative |
| 01/04/2012 | EP2401280A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 01/04/2012 | EP2401279A1 1, 4-disubstituted piperidines as vasopressin receptor via antagonists |
| 01/04/2012 | EP2401276A1 Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors |
| 01/04/2012 | EP2297148B1 Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors |
| 01/04/2012 | EP1986645B1 Glucokinase activators |
| 01/04/2012 | EP1928461B1 Pyrimidine compounds as serotonin receptor modulators |
| 01/04/2012 | CN102307949A Novel azomethine compound and thermal transfer sheet using coloring matter of the azomethine compound |
| 01/04/2012 | CN102307909A Photosensitive resin composition |
| 01/04/2012 | CN102307875A Pyrrolopyrimidinyl axl kinase inhibitors |
| 01/04/2012 | CN102307870A Pyridyloxyindoles inhibitors of VEGF-R2 and use thereof for treatment of disease |
| 01/04/2012 | CN102304141A Calixarene constructed supramolecular polymer material and preparation method thereof |
| 01/04/2012 | CN102304130A Heterocyclical chromophore architectures |
| 01/04/2012 | CN101248078B Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase |
| 01/04/2012 | CN101235037B Method for synthesizing alkoxyporphyrin |
| 01/03/2012 | US8088919 Crystalline forms of pemetrexed diacid and processes for the preparation thereof |
| 01/03/2012 | US8088917 Ionic liquids |
| 01/03/2012 | US8088901 Azaindenofluorenedione derivative, material for organic electroluminescence device and organic electroluminescence device |
| 01/03/2012 | US8088815 Spiroindolinone pyrrolidines |
| 01/03/2012 | US8088780 5,7-disubstituted thiazolo[4,5-D]pyrimidines for the selective inhibition of chemokine receptors |
| 01/03/2012 | US8088779 Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists |
| 01/03/2012 | US8088774 Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death |
| 01/03/2012 | US8088770 Modulators of pharmacokinetic properties of therapeutics |
| 01/03/2012 | US8088769 e.g. 2-(3,4-Dichlorophenyl)ethanamidine hydrochloride; phosphodiesterases inhibitor; learning enhancement, cognition activator; improving perception, concentration, or memory |
| 01/03/2012 | US8088764 Compound useful for the treatment of degenerative and inflammatory diseases |
| 01/03/2012 | US8088759 1,4-benzodiazepine-2,5-diones with therapeutic properties |
| 01/03/2012 | CA2576256C Immunomodulating oxopyrrazolocinnolines as cd80 inhibitors |
| 01/03/2012 | CA2574896C (1s,5s)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate |
| 01/03/2012 | CA2558245C An improved process for the preparation of n-([1,2,4]triazolopyrimidin-2-yl)aryl sulfonamides |
| 01/03/2012 | CA2524525C Novel pyridopyrazines and use thereof as kinase modulators |
| 01/03/2012 | CA2515132C Heteroaryl substituted pyrroles useful as inhibitors of protein kinases |
| 01/03/2012 | CA2495060C Derivatives of pyrrolo-pyrazines having a kinase inhibitory activity and their biological applications |
| 01/03/2012 | CA2494183C Processes for preparing 1,3-dioxolane nucleosides |
| 01/03/2012 | CA2480356C Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/03/2012 | CA2397661C 2,4-disubstituted thiazolyl derivatives |
| 12/29/2011 | WO2011163527A1 Pyrrolo- pyrazine derivatives useful as inhibitors of atr kinase |
| 12/29/2011 | WO2011163518A1 Pyrazolo [1, 5 -a] pyrimidines as antiviral agents |
| 12/29/2011 | WO2011163430A1 Polymorphs of osi-906 |
| 12/29/2011 | WO2011163355A1 Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors |
| 12/29/2011 | WO2011162835A1 Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors |
| 12/29/2011 | WO2011162409A1 Compounds having trpv1 antagonistic activity and uses thereof |
| 12/29/2011 | WO2011162368A1 Novel condensed pyridine or condensed pyrimidine derivative, and medicinal agent comprising same |
| 12/29/2011 | WO2011162320A1 Combination of egcg or methylated egcg and a pde inhibitor |
| 12/29/2011 | WO2011161537A2 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof |
| 12/29/2011 | WO2011161065A1 Macrocyclic tetrapyrrolic compound of the family of porphyrins, chlorins and bacteriochlorins as photosensitizers for photodynamic therapy |
| 12/29/2011 | WO2011161031A1 Benzotriazolodiazepine compounds inhibitors of bromodomains |
| 12/29/2011 | WO2011160757A1 Materials for electronic devices |
| 12/29/2011 | WO2011103524A3 Cyclic tetrapeptides and therapeutic applications thereof |
| 12/29/2011 | US20110319433 Fused heteroaryl pyridyl and phenyl benzenesuflonamides as ccr2 modulators for the treatment of inflammation |
| 12/29/2011 | US20110319394 Fused heterocyclic compounds |
| 12/29/2011 | US20110319393 Anthelmintic agents and their use |
| 12/29/2011 | US20110319385 Quinoxaline compound |
| 12/29/2011 | US20110319380 Compounds for Treating Disorders Mediated by Metabotropic Glutamate Receptor 5, and Methods of Use Thereof |
| 12/29/2011 | US20110319362 Stat3 ligands and therapeutic uses thereof |
| 12/29/2011 | US20110319287 Modulator assay |
| 12/29/2011 | US20110318345 Nasal delivery |
| 12/29/2011 | US20110315975 Material for use in phosphorescent device and organic electroluminescent device using same |
| 12/29/2011 | DE102010025476A1 Komplexe mit Polystyrolsulfonat Complexes with polystyrene sulfonate |
| 12/29/2011 | CA2803802A1 Pyrrolo- pyrazine derivatives useful as inhibitors of atr kinase |
| 12/29/2011 | CA2803156A1 Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors |
| 12/29/2011 | CA2801154A1 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof |
| 12/29/2011 | CA2800834A1 Pyrazolo [1,5-a] pyrimidines as antiviral agents |
| 12/29/2011 | CA2796192A1 Polymorphs of osi-906 |
| 12/29/2011 | CA2788398A1 Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors |
| 12/28/2011 | EP2399918A1 Ring compound |
| 12/28/2011 | EP2399588A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 12/28/2011 | EP2398804A2 Acid addition salt of udenafil, preparation method thereof and phamaceutical composition comprising the same |
| 12/28/2011 | EP2398803A2 Solid state forms of sitagliptin salts |
| 12/28/2011 | EP2398802A1 DERIVATIVES OF 6-CYCLOAMINO-2-THIENYL-3-(PYRIDIN-4-YL)IMIDAZO[1,2-b]-PYRIDAZINE AND 6-CYCLOAMINO-2-FURANYL-3-(PYRIDIN-4-YL)IMIDAZO[1,2-b]-PYRIDAZINE, PREPARATION AND THERAPEUTIC APPLICATION THEREOF |
| 12/28/2011 | EP2398796A1 Heterocyclic derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 12/28/2011 | EP2398782A1 Isoxazole-isoxazole and isoxazole-isothiazole derivatives |
| 12/28/2011 | EP2398777A1 Pyrimidopyridazine derivatives useful as p38 mapk inhibitors |
| 12/28/2011 | EP2398774A2 Processes for preparing jak inhibitors and related intermediate compounds |
| 12/28/2011 | EP2398324A1 PYRAZOLO [4,3-c]CINNOLIN-3-ONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS |
| 12/28/2011 | EP2010537B1 Imidazoquinoxaline compounds as immunomodulators |
| 12/28/2011 | CN102295756A 含咔唑卟啉-噻吩并噻二唑共聚物及其制备方法和应用 Carbazole containing porphyrin - thiophene and thiadiazole copolymer and its preparation method and application |
| 12/28/2011 | CN102295647A 全烷基取代三茚环并三聚吲哚衍生物及其制备方法 Full three indene ring and alkyl-substituted indole derivative trimer and preparation method |
| 12/28/2011 | CN102295646A 含不饱和烃基双环胍的光碱产生剂及其制备方法和用途 Unsaturated hydrocarbon containing bicyclic guanidine produce light base and its preparation method and use |
| 12/28/2011 | CN102295555A 环丙基羧酸酯及其衍生物的制备方法 Preparation of cyclopropyl carboxylic acid esters and derivatives thereof |
| 12/28/2011 | CN102293773A 含有苯并硫氮杂卓和苯并虑平化合物的药物 Benzothiazepine and benzo drugs containing compounds doxepin |